Mesylate salt of an IKK inhibitor
    1.
    发明申请
    Mesylate salt of an IKK inhibitor 审中-公开
    IKK抑制剂的甲磺酸盐

    公开(公告)号:US20090137579A1

    公开(公告)日:2009-05-28

    申请号:US12288596

    申请日:2008-10-22

    IPC分类号: A61K31/5377 C07D413/14

    CPC分类号: C07D471/04

    摘要: The present invention is directed to the compound of formula (II), or a solvate thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (II), including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of a compound of formula (II), or crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.

    摘要翻译: 本发明涉及式(II)化合物或其溶剂化物或其结晶形式; 涉及药物组合物,其包含药学上有效量的式(II)化合物,包括其结晶形式和药学上可接受的载体; 以及使用式(II)化合物或其结晶形式用于治疗患有或受其抑制IKK-2能够改善的病理状况的患者及其相关方法。

    Salts of an IKK inhibitor
    2.
    发明申请
    Salts of an IKK inhibitor 审中-公开
    IKK抑制剂的盐

    公开(公告)号:US20090131422A1

    公开(公告)日:2009-05-21

    申请号:US12288595

    申请日:2008-10-22

    CPC分类号: C07D471/04

    摘要: The present invention is directed to the Tartrate, Mono-Hydrochloride, Malonate and p-Toluenesulfonate Salts of the compound of formula (I), or solvates thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the Salts, including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of the Salts, including crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.

    摘要翻译: 本发明涉及式(I)化合物或其溶剂合物或其结晶形式的酒石酸盐,单盐酸盐,丙二酸盐和对甲苯磺酸盐盐; 涉及包含药学有效量的盐,包括其结晶形式的药物组合物和药学上可接受的载体; 以及使用包括其结晶形式的盐,用于治疗患有或受其抑制IKK-2能够改善的病理状况的患者及其相关方法。